Related Experiment Video
Updated: Jun 13, 2026

11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
[Pediatric anesthesia and upper respiratory tract infections]
1Hôpital des enfants - HUG, 6, rue Willy Donzé, 1205 Genève. Marie.Malisse@hcuge.ch
Revue Medicale Suisse
|April 14, 2010
Summary
Children with respiratory infections face higher risks for surgical complications. Decisions on pediatric anesthesia and surgery require careful case-by-case evaluation due to potential risks and consequences.
Area of Science:
- Pediatric Anesthesiology
- Respiratory Medicine
Context:
- Historically, surgery for children with respiratory illnesses was postponed until symptoms resolved.
- Current data indicate increased postoperative complication risks for children with upper respiratory tract infections (URTIs) up to six weeks post-illness.
- General anesthesia in these children elevates the risk of respiratory events, though significant long-term morbidity is minimal.
Purpose:
- To review evidence-based guidelines for managing anesthesia in children with URTIs.
- To provide a framework for decision-making in daily clinical practice regarding pediatric surgery and anesthesia for children with URTIs.
Summary:
- Children with URTIs are at a heightened risk for postoperative complications following general anesthesia.
- Surgical cancellations due to URTI have substantial emotional, social, and economic impacts.
- There is a lack of consensus on managing these cases, necessitating individualized anesthetic strategies.
Impact:
- Informs clinical practice for pediatric anesthesiologists and surgeons.
- Aims to reduce unnecessary surgical cancellations and associated consequences.
- Highlights the need for evidence-based guidelines in managing pediatric patients with URTIs undergoing anesthesia.
Related Concept Videos
Drugs Used in Upper Respiratory Disorders: Overview
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Inhalational Anesthetics: Overview
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Upper Respiratory Drugs: Decongestants
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in various...
Most decongestants are readily available over-the-counter in various...
Common Respiratory Disorders
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...

